Cubist Systematic Strategies’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-24,364
| Closed | -$9.01M | – | 4336 |
|
|
2023
Q4 | $8.58M | Buy |
24,364
+16,903
| +227% | +$5.98M | 0.06% | 542 |
|
|
2023
Q3 | $2.8M | Sell |
7,461
-5,853
| -44% | -$2.26M | 0.02% | 1123 |
|
|
2023
Q2 | $5.09M | Buy |
13,314
+11,657
| +704% | +$4.16M | 0.03% | 838 |
|
|
2023
Q1 | $574K | Sell |
1,657
-22,459
| -93% | -$6.56M | ﹤0.01% | 2578 |
|
|
2022
Q4 | $5.68M | Sell |
24,116
-54,830
| -69% | -$13M | 0.03% | 905 |
|
|
2022
Q3 | $19.4M | Buy |
78,946
+69,414
| +728% | +$21.1M | 0.11% | 166 |
|
|
2022
Q2 | $2.88M | Buy |
9,532
+7,924
| +493% | +$2.58M | 0.02% | 1507 |
|
|
2022
Q1 | $660K | Buy |
1,608
+244
| +18% | +$95.5K | 0.01% | 2352 |
|
|
2021
Q4 | $640K | Sell |
1,364
-23,902
| -95% | -$10.3M | 0.01% | 2265 |
|
|
2021
Q3 | $10.7M | Buy |
25,266
+7,779
| +44% | +$3.28M | 0.14% | 167 |
|
|
2021
Q2 | $6.28M | Buy |
17,487
+12,509
| +251% | +$4.13M | 0.07% | 411 |
|
|
2021
Q1 | $1.4M | Sell |
4,978
-15,760
| -76% | -$4.51M | 0.02% | 1297 |
|
|
2020
Q4 | $5.88M | Sell |
20,738
-6,020
| -22% | -$1.69M | 0.08% | 374 |
|
|
2020
Q3 | $7.36M | Buy |
26,758
+25,135
| +1,549% | +$6.65M | 0.11% | 253 |
|
|
2020
Q2 | $369K | Sell |
1,623
-4,743
| -75% | -$932K | 0.01% | 1747 |
|
|
2020
Q1 | $969K | Buy |
6,366
+5,544
| +674% | +$853K | 0.03% | 852 |
|
|
2019
Q4 | $124K | Sell |
822
-68,515
| -99% | -$9.98M | ﹤0.01% | 2144 |
|
|
2019
Q3 | $9.83M | Buy |
69,337
+52,355
| +308% | +$7.21M | 0.2% | 106 |
|
|
2019
Q2 | $2.13M | Buy |
16,982
+9,080
| +115% | +$1.07M | 0.04% | 655 |
|
|
2019
Q1 | $871K | Buy |
7,902
+1,175
| +17% | +$122K | 0.03% | 838 |
|
|
2018
Q4 | $659K | Buy |
+6,727
| New | +$730K | 0.03% | 787 |
|
|
2018
Q1 | – | Sell |
-2,949
| Closed | -$291K | – | 2103 |
|
|
2017
Q4 | $291K | Sell |
2,949
-12,083
| -80% | -$1.18M | 0.02% | 1266 |
|
|
2017
Q3 | $1.45M | Buy |
15,032
+10,857
| +260% | +$982K | 0.08% | 274 |
|
|
2017
Q2 | $395K | Buy |
4,175
+1,755
| +73% | +$161K | 0.03% | 868 |
|
|
2017
Q1 | $197K | Buy |
+2,420
| New | +$202K | 0.01% | 1193 |
|
|
2016
Q4 | – | Sell |
-13,713
| Closed | -$1.02M | – | 1904 |
|
|
2016
Q3 | $1.02M | Buy |
13,713
+8,832
| +181% | +$701K | 0.07% | 409 |
|
|
2016
Q2 | $370K | Buy |
+4,881
| New | +$355K | 0.02% | 958 |
|
|
2016
Q1 | – | Sell |
-12,082
| Closed | -$728K | – | 1861 |
|
|
2015
Q4 | $728K | Buy |
12,082
+7,785
| +181% | +$468K | 0.04% | 627 |
|
|
2015
Q3 | $233K | Buy |
+4,297
| New | +$250K | 0.01% | 1384 |
|
|
2015
Q1 | – | Sell |
-17,324
| Closed | -$922K | – | 2099 |
|
|
2014
Q4 | $922K | Buy |
17,324
+11,568
| +201% | +$579K | 0.05% | 546 |
|
|
2014
Q3 | $258K | Sell |
5,756
-5,013
| -47% | -$213K | 0.02% | 1196 |
|
|
2014
Q2 | $454K | Buy |
+10,769
| New | +$461K | 0.03% | 784 |
|
Other funds holding WST
Cubist Systematic Strategies's WST Position: Q1 2024 in Review
Cubist Systematic Strategies sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 24,364 shares — an estimated $9.01M sold.
Cubist Systematic Strategies first reported a position in WST in Q2 2014 and held it in 32 quarters. The position peaked at $19.4M in Q3 2022. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.
- Cubist Systematic Strategies reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 24,364 West Pharmaceutical shares in Q1 2024, an estimated $9.01M.
- Cubist Systematic Strategies first reported a position in West Pharmaceutical in Q2 2014 and held it in 32 quarters.
- Cubist Systematic Strategies's West Pharmaceutical position peaked at $19.4M in Q3 2022.
- 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.
Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.